Squalenoylation: a generic platform for nanoparticular drug delivery.

Abstract

Squalene is a triterpene widely distributed in nature that is an intermediate in the cholesterol biosynthesis pathway. The remarkable dynamic folded conformation of squalene has been used to chemically conjugate this lipid with various therapeutic molecules to construct nanoassemblies of 100-300 nm. In this review, we discuss the new concept of "squalenoylation" through application to anticancer (i.e. gemcitabine, paclitaxel, cisplatin etc.…) or antiviral (ddI, ddC) compounds. In a lego-type approach, it is also possible to construct multifunctional nanoparticles endowed with additional imaging functionalities (i.e. "Nanotheragnostics"). This new nanotechnology platform is expected to have important applications in pharmacology.

DOI: 10.1016/j.jconrel.2011.07.038
02040201220132014201520162017
Citations per Year

66 Citations

Semantic Scholar estimates that this publication has 66 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Desmale2012SqualenoylationAG, title={Squalenoylation: a generic platform for nanoparticular drug delivery.}, author={Didier Desma{\"{e}le and Ruxandra Gref and Patrick Couvreur}, journal={Journal of controlled release : official journal of the Controlled Release Society}, year={2012}, volume={161 2}, pages={609-18} }